Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Drug Therapy × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 47 Breast Neoplasms 22 Lung Neoplasms 18 Pancreatic Neoplasms 15 Neoplasm Metastasis 15 Neoplasms 13 Colorectal Neoplasms 13 Triple Negative Breast Neoplasms 12 Stomach Neoplasms 11 Head and Neck Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Small Cell Lung Carcinoma 9 Rectal Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Uterine Cervical Neoplasms 8 Esophageal Neoplasms 8 Ovarian Neoplasms 7 Leukemia, Myeloid, Acute 6 Cholangiocarcinoma 6 Urinary Bladder Neoplasms 5 Recurrence 5 Fallopian Tube Neoplasms 5 Sarcoma 4 NSCLC 4 Lymphoma 4 Glioblastoma 4 Colonic Neoplasms 4 Carcinoma, Squamous Cell 4 Prostatic Neoplasms 3 Oropharyngeal Neoplasms 3

Interventions

Cyclophosphamide 15 fludarabine phosphate 12 Whole-Body Irradiation 12 Mycophenolic Acid 12 fludarabine 11 Tacrolimus 8 Peripheral Blood Stem Cell Transplantation 8 Busulfan 8 Melphalan 7 Granulocyte Colony-Stimulating Factor 5 Cyclosporine 5 Azacitidine 5 Filgrastim 4 venetoclax 3 Cord Blood Stem Cell Transplantation 3 Biopsy 3 thymoglobulin 2 decitabine and cedazuridine drug combination 2 Vorinostat 2 Thiotepa 2 Specimen Handling 2 Sirolimus 2 Rituximab 2 Methotrexate 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 Cyclosporins 2 Clofarabine 2 Bone Marrow Transplantation 2 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡